智通财经APP获悉，9月17日共有3家上市公司的限售股解禁，解禁总市值约98.52亿元。 今日具体限售解禁股情况如下： | 股票简称 | 股票代码 | 限售股类型 | 解禁股数 | | --- | --- | --- | --- | | 腾远钴业 | 301219 | 延长限售锁定期流通 | 1.18亿 | | 莱特光电 | 688150 | | 2.23亿 | | 格灵深瞳 | 688207 | | 7029.68万 | ...

Group 1 - The State Council will hold two press conferences on September 17, focusing on policies to expand service consumption and the high-quality development of central enterprises during the 14th Five-Year Plan [2] - The 12th Beijing Xiangshan Forum will take place from September 17 to 19, featuring representatives from developed countries, emerging powers, and conflict-affected regions, with increased participation from former military and political leaders and renowned experts [2] - A total of 9 companies will have their restricted shares unlocked today, with a combined unlock volume of 537 million shares, amounting to a market value of 17.886 billion yuan [2] Group 2 - Among the companies with unlocked shares, three have over 10 million shares released: Shenguan Medical (407 million shares), Geling Deep Vision (70.296 million shares), and Blue Focus (52.696 million shares) [3] - In terms of market value, Shenguan Medical leads with 16.122 billion yuan, followed by Geling Deep Vision with 1.237 billion yuan and Blue Focus with 370 million yuan [3] - On September 17, 16 companies reported progress on stock repurchase plans, with three companies disclosing new repurchase proposals and eight companies having their plans approved by shareholders [3] Group 3 - The People's Bank of China will have 304 billion yuan of 7-day reverse repos maturing today, with an operation rate of 1.40% [4] - Upcoming data releases include the U.S. EIA crude oil inventory and the U.K. August CPI month-on-month rate [4]

Summary of Key Points Core Viewpoint - On September 17, a total of 9 companies had their restricted shares unlocked, with a total unlock volume of 537 million shares, amounting to a market value of 17.886 billion yuan based on the latest closing prices [1] Group 1: Unlock Volume - Three companies had unlock volumes exceeding 10 million shares: Shenguan Medical (40.7 million shares), Geling Deep Vision (7.02968 million shares), and BlueFocus Communication Group (5.2696 million shares) [1] Group 2: Unlock Market Value - Three companies had unlock market values exceeding 100 million yuan: Shenguan Medical (16.122 billion yuan), Geling Deep Vision (1.237 billion yuan), and BlueFocus Communication Group (370 million yuan) [1] Group 3: Unlock Ratio - Two companies had unlock ratios exceeding 10% of their total share capital: Shenguan Medical (69.83%) and Geling Deep Vision (27.14%), while BlueFocus Communication Group had an unlock ratio of 1.47% [1]

Core Viewpoint - The company, Geling Shentong, reported a significant decline in revenue and increased net losses for the first half of 2025 compared to the same period in the previous year [1][2]. Financial Performance - For the first half of 2025, the company achieved operating revenue of 42.47 million yuan, a decrease of 17.22% year-on-year from 51.31 million yuan [1][2]. - The net profit attributable to shareholders was -79.85 million yuan, compared to -77.92 million yuan in the same period last year [1][2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -85.58 million yuan, slightly worse than -81.54 million yuan in the previous year [1][2]. - The net cash flow from operating activities was -103.12 million yuan, worsening from -87.40 million yuan year-on-year [1][2]. Historical Financial Data - In 2023 and 2024, the company's operating revenues were 262.00 million yuan and 117.24 million yuan, respectively, indicating a 55.30% decline in 2024 compared to 2023 [3]. - The net profit attributable to shareholders for 2024 was -211.60 million yuan, compared to -90.33 million yuan in 2023 [3]. - The net cash flow from operating activities in 2024 was -146.50 million yuan, compared to -31.24 million yuan in 2023 [3]. Initial Public Offering (IPO) Details - Geling Shentong raised a total of 1.826 billion yuan from its IPO, with a net amount of 1.670 billion yuan after deducting issuance costs [4]. - The company initially planned to raise 1.000 billion yuan for various projects, including AI algorithm platform upgrades and marketing service system enhancements [4]. - The total number of shares increased to 258,973,147 after a capital increase distribution to shareholders [4].

Group 1 - The core viewpoint of the news is the performance and market position of Beijing Geling Deep Vision Technology Co., Ltd., which has seen a stock price increase of 5.13% to 17.64 CNY per share, with a total market capitalization of 4.568 billion CNY [1] - The company specializes in integrating advanced computer vision and big data analysis technologies into various application scenarios, providing AI products and solutions for urban management, smart finance, commercial retail, sports health, and rail transit operations [1] - The revenue composition of the company includes 58.58% from AI products, 26.46% from smart terminal products, and 14.95% from technical services and others [1] Group 2 - From the perspective of fund holdings, Geling Deep Vision is a significant investment for the Yinhua Fund, with the 2000 Enhanced ETF (159555) holding 24,700 shares, representing 0.81% of the fund's net value [2] - The 2000 Enhanced ETF has achieved a year-to-date return of 43.19% and a one-year return of 104.51%, ranking 686 out of 4222 and 330 out of 3804 in its category, respectively [2] - The fund manager Zhang Kai has a tenure of over 12 years, with the best fund return during his management being 130.54%, while Zhang Yichi has been managing for over 4 years with a best return of 56.45% [3]

Group 1 - The company, Geling Deep Vision, announced a change in its sponsor representatives for the ongoing supervision of its initial public offering (IPO) [2] - The new sponsor representatives are Mr. Wang Pengcheng and Mr. Kong Haibin [2]

国泰海通证券股份有限公司 关于北京格灵深瞳信息技术股份有限公司 使用部分超募资金及部分节余募集资金 永久补充流动资金的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐人"）作为北 京格灵深瞳信息技术股份有限公司（以下简称"格灵深瞳"、"公司"或"发行人"） 首次公开发行股票并在科创板上市的持续督导保荐机构，根据《证券发行上市保 荐业务管理办法》《上市公司募集资金监管规则》《上海证券交易所科创板股票上 市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等有关规定，对公司使用部分超募资金及部分节余募集资金永久补充流动资金的 事项进行了核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意北京格灵深瞳信息技术股份有限公司 首次公开发行股票注册的批复》（证监许可〔2022〕64 号）核准，公司首次向社 会公众公开发行人民币普通股（A 股）46,245,205 股，发行价为人民币 39.49 元/ 股，募集资金总额为人民币 182,622.31 万元，扣除不含税券商承销费用和保荐费 用 12,783.56 万元后的募集资金为 169,838.75 万元， ...

国泰海通证券股份有限公司 | 项 目 | 工作内容 | | --- | --- | | 1、建立健全并有效执行持续督导工作制度，针 | 保荐机构已建立健全并有效执行持续督导工 | | 对公司的具体情况确定持续督导的内容和重 | 作制度，针对公司的具体情况确定持续督导的 | | 点，督导公司履行有关上市公司规范运作、信 | 内容和重点，督导公司履行有关上市公司规范 | | 守承诺和信息披露等义务，审阅信息披露文件 | 运作、信守承诺和信息披露等义务，审阅信息 | | 及向中国证监会、证券交易所或其他机构提交 | 披露文件及向中国证监会、证券交易所或其他 | | 的其他文件，并按保荐办法要求承担相关持续 | 机构提交的其他文件，并按保荐办法要求承担 | | 督导工作。 | 相关持续督导工作。 | | 2、根据上市规则规定，与公司就持续督导期间 | 保荐机构已与上市公司签署了持续督导协议， | | | 协议明确了双方在持续督导期间的权利和义 | | 的权利义务签订持续督导协议。 | 务。 | | | 保荐机构已协助和督促上市公司建立相应的 | | 3、协助和督促上市公司建立相应的内部制度、 | 内部制度、决策程序及 ...

北京格灵深瞳信息技术股份有限公司 董事、高级管理人员所持本公司股份及其变动管理制度 第一章 总则 第一条 为加强北京格灵深瞳信息技术股份有限公司（以下简称"公司"） 董事和高级管理人员所持本公司股份及其变动的管理，维护证券市场秩序，根据 《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和国证券 法》（以下简称"《证券法》"）《上海证券交易所科创板股票上市规则》《上 市公司董事和高级管理人员所持本公司股份及其变动管理规则》《上海证券交易 所上市公司自律监管指引第 15 号——股东及董事、高级管理人员减持股份》（以 下简称"《自律监管指引第 15 号》"）等有关法律、法规、规范性文件及《北 京格灵深瞳信息技术股份有限公司章程》（以下简称"《公司章程》"）的有关 规定，结合公司实际情况，制订本制度。 第二条 本制度适用于公司董事和高级管理人员所持本公司股份及其变动 的管理。其所持本公司股份是指登记在其名下和利用他人账户持有的所有本公司 股份。 第三条 公司董事和高级管理人员就其所持股份变动相关事项作出承诺的， 应当严格遵守。 第四条 公司董事和高级管理人员在买卖公司股票及其衍生品种前，应知悉 《公司法 ...

北京格灵深瞳信息技术股份有限公司 内幕信息知情人登记备案制度 第一章 总则 第一条 为加强北京格灵深瞳信息技术股份有限公司（以下简称"公司"） 内幕信息管理，做好内幕信息保密工作，维护信息披露的公平原则，保护广大投 资者的合法权益，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司信息披露 管理办法》《上海证券交易所科创板股票上市规则》《上市公司监管指引第 5 号——上市公司内幕信息知情人登记管理制度》（以下简称"《监管指引第 5 号》"）《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等有关法律法规，及《北京格灵深瞳信息技术股份有限公司章程》（以下简称"《公 司章程》"）《北京格灵深瞳信息技术股份有限公司信息披露管理制度》等规定， 结合公司实际情况，制定本制度。 第二条 公司董事会是内幕信息的管理机构，董事会应当按照《监管指引第 5 号》以及上海证券交易所相关规则要求及时登记和报送内幕信息知情人档案， 并保证内幕信息知情人档案真实、准确和完整，董事长为主要责任人。董事会秘 书负责办理上市公司内幕信息知情人的登记入档和报 ...